ASGR1 and hepatocellular carcinoma: Sialic acid glycoprotein receptor (ASGPR) is a promising drug target for the HCC treatment because of its high expression on the surface of HCC cell line (Poelstra et al., 2012; Nair et al., 2019; Zhang et al., 2019).